Literature DB >> 8114948

gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors.

G Engberg1, H Nissbrandt.   

Abstract

In the present study the actions of gamma-hydroxybutyric acid (GHBA) on dopaminergic neurons in the rat substantia nigra (SN) were pharmacologically analysed utilising extracellular single unit recording techniques. Intravenous administration of GHBA was associated with several effects on the neuronal activity of nigral dopamine (DA) neurons. Low doses (< 200 mg/kg) of GHBA produced a slight excitation of the neurons, concomitant with a regularized firing rhythm and lack of burst activity. In higher doses GHBA produced an even higher degree of regularization but, in contrast to low doses, an inhibition of firing rate. Administration of the GABAB-receptor agonist baclofen, in all essential respects, mimicked the effect of GHBA on the firing of nigral DA neurons. Both the regularization of the firing pattern and inhibition of firing rate produced by systemic administration of GHBA were antagonised by the GABAB-receptor antagonist CGP 35348 (200 mg/kg, i.v.). Our observations show that GHBA affects the firing pattern of nigral DA neurons in doses considerably lower than those required to inhibit the firing rate of the neurons. This action, as well as the decreased firing rate observed after high doses of GHBA, are mediated via activation of GABAB-receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8114948     DOI: 10.1007/bf00173208

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry.

Authors:  F G Gonon
Journal:  Neuroscience       Date:  1988-01       Impact factor: 3.590

2.  Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo.

Authors:  T H Svensson; C S Tung
Journal:  Acta Physiol Scand       Date:  1989-05

Review 3.  Gamma-hydroxybutyrate, a possible neurotransmitter.

Authors:  P Vayer; P Mandel; M Maitre
Journal:  Life Sci       Date:  1987-09-28       Impact factor: 5.037

4.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

Authors:  A A Grace; B S Bunney
Journal:  Neuroscience       Date:  1983-10       Impact factor: 3.590

5.  Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro.

Authors:  P Vayer; P Mandel; M Maitre
Journal:  J Neurochem       Date:  1985-09       Impact factor: 5.372

6.  Effects of frequency and pattern of medial forebrain bundle stimulation on caudate dialysate dopamine and serotonin.

Authors:  L D Manley; R Kuczenski; D S Segal; S J Young; P M Groves
Journal:  J Neurochem       Date:  1992-04       Impact factor: 5.372

7.  GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra.

Authors:  G Engberg; T Kling-Petersen; H Nissbrandt
Journal:  Synapse       Date:  1993-11       Impact factor: 2.562

8.  Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements.

Authors:  R Romo; W Schultz
Journal:  J Neurophysiol       Date:  1990-03       Impact factor: 2.714

9.  High affinity binding sites for gamma-hydroxybutyric acid in rat brain.

Authors:  J Benavides; J F Rumigny; J J Bourguignon; C Cash; C G Wermuth; P Mandel; G Vincendon; M Maitre
Journal:  Life Sci       Date:  1982-03-15       Impact factor: 5.037

10.  Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats.

Authors:  M Diana; G Mereu; A Mura; F Fadda; N Passino; G Gessa
Journal:  Brain Res       Date:  1991-12-06       Impact factor: 3.252

View more
  9 in total

1.  Blockade of substantia nigra dopamine D1 receptors reduces intravenous cocaine reward in rats.

Authors:  Matthew G Quinlan; Ruth Sharf; David Y Lee; Roy A Wise; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2004-02-07       Impact factor: 4.530

2.  The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice.

Authors:  H Nissbrandt; G Engberg
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Authors:  Daniel Pardi; Jed Black
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.

Authors:  P Bredeloux; I Dubuc; J Costentin
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

5.  Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans.

Authors:  Oliver G Bosch; Fabrizio Esposito; Michael M Havranek; Dario Dornbierer; Robin von Rotz; Philipp Staempfli; Boris B Quednow; Erich Seifritz
Journal:  Neuropsychopharmacology       Date:  2017-05-31       Impact factor: 7.853

6.  Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures.

Authors:  Nicolas Gervasi; Zohreh Monnier; Pierre Vincent; Daniele Paupardin-Tritsch; Stuart W Hughes; Vincenzo Crunelli; Nathalie Leresche
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

Review 7.  Cocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system.

Authors:  Matthew C Hearing; Anastasia N Zink; Kevin Wickman
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

Review 8.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

Review 9.  Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy.

Authors:  Yves Dauvilliers; Richard K Bogan; Karel Šonka; Markku Partinen; Nancy Foldvary-Schaefer; Michael J Thorpy
Journal:  Nat Sci Sleep       Date:  2022-03-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.